Summary
⚈ The sales come amid Dimon’s recession warning tied to trade tariffs.
⚈ Despite insider selling, JPM shares are up over 16% following strong Q1 earnings.
Linda Bammann, chair of the Directors’ Risk Policy Committee at JPMorgan (NYSE: JPM), has sold over $2 million of the company’s common stock in a notable insider trade.
The transaction, executed on May 6, involved the sale of 9,500 JPM shares at $250 each, totaling $2,375,000, according to regulatory filings.
The day before, on May 5, Bammann disposed of an additional 500 shares, though this was classified under code “G”, typically used to denote gifts or internal transfers. Its reported value was $0, suggesting no cash exchanged hands for that portion.
No specific reason for the transactions was disclosed. However, the timing comes less than a month after JPMorgan CEO Jamie Dimon also made headlines for selling a significant portion of his stake.
As reported by Finbold, Dimon sold 133,639 shares at $231.34 each on April 14, netting approximately $31.5 million.
The sale was part of a pre-arranged Rule 10b5-1 trading plan under which Dimon intends to sell 1 million shares by August 1.
While these sales are legally scheduled, they coincide with Dimon’s increasingly cautious economic outlook. The longtime executive has warned that fallout from trade tariffs imposed by President Donald Trump could tip the U.S. economy into a recession.
JPM stock price analysis
At the time of writing, JPM stock was trading at $249, down 1.3% in the last session. Still, JPM’s share price has gained over 16% in the past month, fueled by a strong first-quarter earnings report.
In Q1, the banking giant reported $14.6 billion in net income and $5.07 per share earnings. Revenue rose 8% year-over-year to $46 billion, boosted by gains in asset management and investment banking fees.
Featured image via Shutterstock
